Search research articles
Contact Us
Filters
Showing results (11-20 of 148) with videos related to
Page
of 15
Sort By:
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1982
Alpha-Adrenergic and 5-hydroxytryptaminergic receptor stimulants as new antihypertensive drugs, with observations on involvement of opiate receptors
T Baum, F T Becker
Neuropharmacology
|
September 1, 1970
Inhibition of spontaneous sympathetic nerve activity by the antihypertensive agent Wy-8678
T Baum, A T Shropshire
Journal of the American Dental Association (1939)
|
November 1, 1972
Reduction of x-ray dose by variable rectangular collimation and reflex optical direction of dental x-ray beams and by the supine position of the patient
A T Baum, E Morgan
Archives Internationales De Pharmacodynamie Et De Therapie
|
May 1, 1979
Interaction of cardiopulmonary chemoreceptor (Bezold-Jarisch) and somatosympathetic reflexes
T Baum, A T Shropshire
Neuropharmacology
|
March 1, 1975
Inhibition of efferent sympathetic nerve activity by 5-hydroxytryptophan and centrally administered 5-hydroxytryptamine
T Baum, A T Shropshire
Dental Survey
|
March 1, 1971
Surgical-orthodontic treatment of skeletal Class 3 bimaxillary prognathism, report of a case
A T Baum, M Robinson
European Journal of Pharmacology
|
May 1, 1976
Studies on the centrally mediated hypotensive activity of guanabenz
T Baum, A T Shropshire
Journal of Cardiovascular Pharmacology
|
March 1, 1982
Hypotensive and postural effects of the gamma-aminobutyric acid agonist muscimol and of clonidine
T Baum, F T Becker
Neuropharmacology
|
January 1, 1973
Reduction of sympathetic outflow by central administration of L-DOPA, dopamine and norepinephrine
T Baum, A T Shropshire
The American Journal of Physiology
|
June 1, 1974
Influence of heart rate on the reduction of sympathetic outflow produced by L-dopa
T Baum, A T Shropshire
Page
of 15
Search research articles
Search
Showing results (11-20 of 148) with videos related to
Sort By:
Page
of 15
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1982
Alpha-Adrenergic and 5-hydroxytryptaminergic receptor stimulants as new antihypertensive drugs, with observations on involvement of opiate receptors
T Baum, F T Becker
Neuropharmacology
|
September 1, 1970
Inhibition of spontaneous sympathetic nerve activity by the antihypertensive agent Wy-8678
T Baum, A T Shropshire
Journal of the American Dental Association (1939)
|
November 1, 1972
Reduction of x-ray dose by variable rectangular collimation and reflex optical direction of dental x-ray beams and by the supine position of the patient
A T Baum, E Morgan
Archives Internationales De Pharmacodynamie Et De Therapie
|
May 1, 1979
Interaction of cardiopulmonary chemoreceptor (Bezold-Jarisch) and somatosympathetic reflexes
T Baum, A T Shropshire
Neuropharmacology
|
March 1, 1975
Inhibition of efferent sympathetic nerve activity by 5-hydroxytryptophan and centrally administered 5-hydroxytryptamine
T Baum, A T Shropshire
Dental Survey
|
March 1, 1971
Surgical-orthodontic treatment of skeletal Class 3 bimaxillary prognathism, report of a case
A T Baum, M Robinson
European Journal of Pharmacology
|
May 1, 1976
Studies on the centrally mediated hypotensive activity of guanabenz
T Baum, A T Shropshire
Journal of Cardiovascular Pharmacology
|
March 1, 1982
Hypotensive and postural effects of the gamma-aminobutyric acid agonist muscimol and of clonidine
T Baum, F T Becker
Neuropharmacology
|
January 1, 1973
Reduction of sympathetic outflow by central administration of L-DOPA, dopamine and norepinephrine
T Baum, A T Shropshire
The American Journal of Physiology
|
June 1, 1974
Influence of heart rate on the reduction of sympathetic outflow produced by L-dopa
T Baum, A T Shropshire
Page
of 15